Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Tailoring rTMS for Post-Stroke Aphasia Based on Language Profile

Official title: Recovery From Post-Stroke Aphasia With rTMS Targeting the Anterior Temporal Lobe: Interhemispheric Activation Changes and Lesion-Connectome-Based Predictive Outcomes

Run by University of South Carolina · NCT07608588 · Data updated 2026-11-12

A non-drug brain stimulation approach is tested to see if customizing rTMS targets improves language recovery in people with aphasia after a left-brain stroke.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment45 (estimated)
SponsorUniversity of South Carolina
Academic / other
Locations1 site (Columbia, South Carolina)
StatusRecruiting
StartedMay 15, 2026
Main results expectedJuly 30, 2027
Study endsJuly 30, 2027
Registry record updatedMay 29, 2026
Trial IDNCT07608588 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a single left-hemispheric stroke and lexicosemantic aphasia who are native English speakers and right-handed.

Probably not a fit

Individuals with severe auditory comprehension impairment, left ATL involvement, other major contraindications to MRI or rTMS, or significant cognitive/psychiatric issues may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial explores whether customizing repetitive transcranial magnetic stimulation (rTMS) targets according to a patient’s lexicosemantic profile can improve recovery from post-stroke aphasia. Participants receive different rTMS paradigms (continuous or intermittent theta burst) or sham stimulation, alongside semantic feature analysis tasks to support language therapy. Functional MRI will be used to study how excitatory vs inhibitory stimulation affects interhemispheric balance and network connectivity related to language. The study also aims to understand how stroke location and brain connectivity modulate individual responses to rTMS, potentially explaining variability in outcomes.

Why it matters

Potential benefit: If successful, the approach could yield more effective, personalized brain stimulation strategies to enhance language rehabilitation after stroke.

How similar studies have gone: Previous studies show mixed results for standard targets; this study investigates whether personalized targets improve outcomes, representing a broader, potentially more successful approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Right-handedness (assesed using the Edinburgh Handedness Inventory)
* Native English speakers
* Single left hemispheric stroke
* Diagnosis of aphasia and lexicosemantic impairments (e.g., anomia, semantic errors in picture naming or spontaneous speech) confirmed by a Speech and Language Pathologist or Physician

Exclusion Criteria:

* Severely impaired auditory comprehension (WAB Comprehension score of 0 or 1)
* Major phonological impairments (defined as \> 2 errors in non-word repetition of one- and two-syllable items on the PALPA, 2)
* Contraindications to rTMS (e.g., uncontrolled epilepsy, history of seizures, intracranial ferromagnetic body, cochlear implant, or factors that lower seizure threshold (see Rossi et al., 2021)
* Contraindication to MRI
* Stroke involving the left ATL
* Severe depression or psychiatric history
* Illiteracy
* Known neurodegenerative disorders
* Severe uncorrected visual or hearing impairments

Where it's running

  • McCausland Center
    Columbia, South Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.